Sotera Health Reports Second-Quarter and First-Half 2021 Results; Increases 2021 Outlook

Company reports that Q2 2021 Adjusted EBITDA of $135 million increased approximately 18%, compared to Q2 2020

June 30, 2021 net debt of $1.7 bil

Sotera Health is increasing full-year 2021 revenueg rowth outlook from 9%-12% to 12%-15% and increasing full-year 2021 Adjusted EBITDA growth outlook from 11%-16% to 13%-17%

According to current 2021 outlook, company expects adjusted EBITDA to be in the range of $475-490 million

Sotera completed initial public offering on November 14th, 2020 at an IPO price of $23 per share

Shares are down 3.6% at the beginning of trading on Aug-12-2021

https://www.sec.gov/Archives/edgar/data/1822479/000182247921000050/august122021-ex991.htm

https://investors.soterahealth.com/news-releases/news-release-details/sotera-health-announces-closing-initial-public-offering